Securities code: Thalys Medical Technology Group Corporation(603716) securities abbreviation: Thalys Medical Technology Group Corporation(603716) Announcement No.: 2022016
Bond Code: 113601 bond abbreviation: Saili convertible bond
Thalys Medical Technology Group Corporation(603716)
Announcement on canceling the special account for raised funds of some convertible bonds
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
1、 Basic information of raised funds
Approval of Thalis Medical Technology Co., Ltd. issued by China Securities Regulatory Commission
Approval of the reply to the public offering of convertible corporate bonds (zjxk [2020] No. 1033), Thales medical
Therapeutic Technology Group Co., Ltd. (hereinafter referred to as "the company") was publicly offered on August 21, 2020
The total value of convertible corporate bonds is 543.31 million yuan, and the total amount of funds raised is 543.31 million yuan, deducting underwriting and recommendation expenses and other issuance expenses directly related to the issuance of convertible corporate bonds (excluding
The net amount of raised funds after VAT is 53329867925 yuan. The above funds have been released in 2020
All of them were in place on August 27, and approved by Zhongshen Zhonghuan Certified Public Accountants (special general partnership) in 2020
Verification of the capital verification report (zhyz (2020) No. 010054) issued on August 27, 2014. Deduction of underwriting recommendation fee
And other issuance expenses (including value-added tax) directly related to the issuance of convertible corporate bonds
The net capital is 53269800000 yuan.
2、 Management of raised funds
The company has complied with the company law of the people's Republic of China, the securities law of the people's Republic of China and
Municipal measures for the administration of securities issuance of companies, guidelines for the supervision of listed companies No. 2 - funds raised by listed companies
The measures for the administration of raised funds have been formulated in accordance with the requirements of laws and regulations such as the regulatory requirements for the management and use of raised funds and the stock listing rules of Shanghai Stock Exchange. According to the company's fund-raising management system, the company opened
A special bank account shall be used to store the raised funds.
Approved by the 27th meeting of the third board of directors, the company and the sponsor Cinda securities and China Merchants
Wuhan Dongxihu sub branch of Bank of China Limited (Account No.: 127905615310515), China China Minsheng Banking Corp.Ltd(600016) shares
Wuhan Branch (Account No.: 632278594) and Bank Of China Limited(601988) Wuhan East Lake New Technology Development Zone Branch (Account No.: 558678905094) signed the tripartite supervision agreement on the storage of special account for raised funds, opened a special account for raised funds and stored the raised funds in a special account. There is no significant difference between the above regulatory agreement and the tripartite regulatory agreement on special account storage of raised funds of Shanghai Stock Exchange, and there is no problem in the performance of the regulatory agreement.
The specific conditions of the company's special account for raising funds through public issuance of convertible corporate bonds are as follows:
Account No. remarks of deposit bank
China Minsheng Banking Corp.Ltd(600016) Wuhan Branch 632278594-
China Merchants Bank Co.Ltd(600036) Wuhan Dongxihu sub branch 127905615310515-
Bank Of China Limited(601988) Wuhan East Lake New Technology Development Zone Branch 558678905094 account closed this time
3、 Cancellation of the special account for the raised funds
Whereas the purpose of the raised funds deposited by Bank Of China Limited(601988) Wuhan East Lake New Technology Development Zone Branch (bank account No.: 558678905094) has been completed, and the remaining interest of 341800 yuan has been transferred to the special account for raised funds of other convertible bonds of the company. In order to facilitate the management of the fund account of the company and reduce the management cost, The company has recently cancelled the fund-raising account of Bank Of China Limited(601988) Wuhan East Lake New Technology Development Zone Branch (bank account No.: 558678905094). As of the date of this announcement, the company has completed the cancellation procedures of the above special fund-raising account. After the cancellation of the special account for raised funds, the tripartite supervision agreement on the storage of special account for raised funds signed by the company, Bank Of China Limited(601988) Wuhan East Lake New Technology Development Zone Branch and the sponsor will be terminated accordingly.
It is hereby announced.
Thalys Medical Technology Group Corporation(603716) board of directors March 15, 2022
